These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8422019)

  • 21. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The laboratory heterogeneity of lupus anticoagulants.
    Triplett DA; Brandt JT; Maas RL
    Arch Pathol Lab Med; 1985 Oct; 109(10):946-51. PubMed ID: 3929747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Systematic review of the presentation of coagulation factor VIII inhibitors in rheumatic diseases: A potential cause of life-threatening hemorrhage.
    O'Connor CR
    Semin Arthritis Rheum; 2015 Jun; 44(6):695-709. PubMed ID: 25595725
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dilute Russell's viper venom and activated partial thromboplastin time in lupus anticoagulant diagnosis: is mixing essential?
    Chandrashekar V
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):408-11. PubMed ID: 26626041
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Improved confirmation of weak lupus anticoagulants by employing sensitive and insensitive reagents to the lupus anticoagulant.
    Ames PR; Iannaccone L; De Iasio R; Brancaccio V
    Blood Coagul Fibrinolysis; 2001 Oct; 12(7):563-7. PubMed ID: 11685045
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Behavior of diluted activated partial thromboplastin time in pregnant women with a lupus anticoagulant.
    Blanco AN; Grand BE; Pieroni G; Peñalva LB; Voto LS; Lazzari MA
    Am J Clin Pathol; 1993 Aug; 100(2):99-102. PubMed ID: 8356956
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of the mixing test in laboratory diagnoses of lupus anticoagulant: the fate of the mixing test in integrated lupus anticoagulant test systems.
    Hong SK; Hwang SM; Kim JE; Kim HK
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):739-44. PubMed ID: 22964767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of sensitivity and specificity of a standardized procedure using different reagents for the detection of lupus anticoagulants. The Working Group on Hemostasis of the Société Française de Biologie Clinique and for the Groupe d'Etudes sur I'Hémostase et la Thrombose.
    Goudemand J; Caron C; De Prost D; Derlon A; Borg JY; Sampol J; Sié P
    Thromb Haemost; 1997 Feb; 77(2):336-42. PubMed ID: 9157593
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lupus anticoagulant in Nigerian women with preeclampsia.
    Awodu OA; Shokunbi WA; Ejele OA
    West Afr J Med; 2003 Sep; 22(3):240-2. PubMed ID: 14696949
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new lupus anticoagulant neutralization test based on platelet-derived vesicles.
    Arnout J; Huybrechts E; Vanrusselt M; Vermylen J
    Br J Haematol; 1992 Mar; 80(3):341-6. PubMed ID: 1581214
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silica clotting time (SCT) as a screening and confirmatory test for detection of the lupus anticoagulants.
    Chantarangkul V; Tripodi A; Arbini A; Mannucci PM
    Thromb Res; 1992 Aug; 67(4):355-65. PubMed ID: 1329261
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Laboratory diagnosis of lupus anticoagulants for patients on oral anticoagulant treatment. Performance of dilute Russell viper venom test and silica clotting time in comparison with Staclot LA.
    Tripodi A; Chantarangkul V; Clerici M; Mannucci PM
    Thromb Haemost; 2002 Oct; 88(4):583-6. PubMed ID: 12362227
    [TBL] [Abstract][Full Text] [Related]  

  • 33. dRVVT is more sensitive than KCT or TTI for detecting lupus anticoagulant activity of anti-beta2-glycoprotein I autoantibodies.
    Pengo V; Biasiolo A; Rampazzo P; Brocco T
    Thromb Haemost; 1999 Feb; 81(2):256-8. PubMed ID: 10064002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant.
    Forastiero RR; Falcón CR; Carreras LO
    Haemostasis; 1990; 20(4):208-14. PubMed ID: 2122955
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of lupus anticoagulant in women with spontaneous abortion in Zaria.
    Ibrahim IN; Mamman AI; Adaji SE; Hassan A; Babadoko AA
    Niger J Clin Pract; 2017 Sep; 20(9):1145-1149. PubMed ID: 29072238
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Concomitant factor VIII inhibitor and lupus anticoagulant in an asymptomatic patient.
    Jacobs JW; Gisriel SD; Iyer K; Rinder HM
    J Thromb Thrombolysis; 2022 May; 53(4):945-949. PubMed ID: 34697688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. PARTIAL THROMBOPLASTIN TIME TEST WITH KAOLIN. NORMAL RANGE AND MODIFICATIONS FOR THE DIAGNOSIS OF HAEMOPHILIA AND CHRISTMAS DISEASE.
    MATCHETT MO; INGRAM GI
    J Clin Pathol; 1965 Jul; 18(4):465-71. PubMed ID: 14318702
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lupus anticoagulant syndrome: case report.
    Mwanda OW
    East Afr Med J; 1998 Oct; 75(10):619-20. PubMed ID: 10065201
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Coexistence of lupus anticoagulant and acquired haemophilia in a patient with monoclonal gammopathy of unknown significance.
    Taher A; Abiad R; Uthman I
    Lupus; 2003; 12(11):854-6. PubMed ID: 14667103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Difficulties in laboratory diagnosis of coexistent lupus anticoagulant and factor VIII inhibitors: case report and review of literature.
    Belhadj M; Cheikhrouhou M; Guermazi S
    Ann Biol Clin (Paris); 2023 Oct; 81(4):417-423. PubMed ID: 37791505
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.